| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 03/16/2011 | CN101260075B Aralkylpiperidine derivative and application thereof in preparing analgesic and sedative medicament |
| 03/15/2011 | US7906657 1,5-diphenylpyrazoles II as HSP90 inhibitors |
| 03/15/2011 | US7906646 Spirocyclic heterocyclic derivatives and methods of their use |
| 03/15/2011 | US7906644 2,4-pyrimidinediamine compounds and their uses |
| 03/15/2011 | US7906629 Protease inhibitor conjugates and antibodies useful in immunoassay |
| 03/15/2011 | US7906546 Tetrahydrocarbazoles and derivatives |
| 03/15/2011 | US7906545 Prodrugs of CC-1065 analogs |
| 03/15/2011 | US7906539 Imidazoles and triazoles, their preparation, and their use as pharmaceutical compositions |
| 03/15/2011 | US7906533 Nicotinamide pyridinureas as vascular endothelial growth factor (VEGF) receptor kinase inhibitors |
| 03/15/2011 | US7906523 retrovirus inhibor; anticarcinogenic, antidiabetic agent, immunosuppressant, autoimmune diseases; 2-{6-[3(R)-Amino-piperidin-1-yl]-3-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethyl}-4-fluoro-benzonitrile; type 2 diabetes mellitus, impaired glucose tolerance, obesity, multiple sclerosis |
| 03/15/2011 | US7906516 Carbonyl compounds |
| 03/15/2011 | US7906513 Prevent reproduction; breaking life cycle;viricides |
| 03/15/2011 | US7906512 3,6-substituted imidazol[1,2-b]pyridazine analogs for treating allergic and inflammatory diseases |
| 03/15/2011 | US7906511 Cyclic compound having pyrimidinylalkylthio group |
| 03/15/2011 | US7906509 Inhibitors of bruton's tyrosine kinase |
| 03/15/2011 | US7906503 Substituted 3-alkyl and 3-alkenyl azetidine derivatives |
| 03/15/2011 | US7906039 Fluorescent diketopyrrolopyrroles |
| 03/15/2011 | CA2630665C Heterocyclic compound having inhibitory activity on 11-.beta.-hydroxysteroid dehydrogenase type i |
| 03/15/2011 | CA2550596C 3-cycloalkylaminopyrrolidine derivatives as modulators of chemokine receptors |
| 03/15/2011 | CA2477774C Indolylmaleimide derivatives |
| 03/15/2011 | CA2473910C Pyrimidine derivatives as rho-kinase inhibitors |
| 03/15/2011 | CA2431160C Anilinopyrimidine derivatives as ikk inhibitors and compositions and methods related thereto |
| 03/15/2011 | CA2426921C Low hygroscopic aripiprazole drug substance and processes for the preparation thereof |
| 03/15/2011 | CA2426440C Quinazoline derivatives as kinase inhibitors |
| 03/15/2011 | CA2407939C Diazacycloalkane derivatives as bleach catalyst and composition and method for bleaching a substrate |
| 03/15/2011 | CA2315117C Heterocyclic ether and thioether compounds useful in controlling chemical synaptic transmission |
| 03/15/2011 | CA2232191C Inhibition of tumor necrosis factor alpha |
| 03/10/2011 | WO2011028995A1 Compounds as tyrosine kinase modulators |
| 03/10/2011 | WO2011028947A2 Heterocyclic compounds for the inhibition of pask |
| 03/10/2011 | WO2011028741A1 Quinazolines as potassium ion channel inhibitors |
| 03/10/2011 | WO2011027849A1 Heterocyclic compound |
| 03/10/2011 | WO2011027326A1 Process for the preparation of lenalidomide |
| 03/10/2011 | WO2011027249A2 Benzimidazole derivatives |
| 03/10/2011 | WO2011027156A1 Benzodiazepine derivatives for treating hepatitis c infection |
| 03/10/2011 | WO2011026959A1 Novel ethane diamine hepcidin antagonists |
| 03/10/2011 | WO2011026920A1 Bis-benzimidazole derivatives |
| 03/10/2011 | WO2011026917A1 Heteroaryl compounds as kinase inhibitors |
| 03/10/2011 | WO2011026911A1 Bipyridines useful for the treatment of proliferative diseases |
| 03/10/2011 | WO2011026904A1 Pyrazinylpyridines useful for the treatment of proliferative diseases |
| 03/10/2011 | WO2011026835A1 Novel pyrimidine and triazine hepcidine antagonists |
| 03/10/2011 | WO2011026579A1 Substituted aminoquinoxalines as tyrosine threonine kinase inhibitors |
| 03/10/2011 | WO2010147302A3 Novel intermediates of voriconazole and preparation method of voriconazole using the same |
| 03/10/2011 | WO2010117756A3 Substituted benzimidazole pharmaceutical formulations |
| 03/10/2011 | US20110060015 5-[5-[2-(3,5-BIS(Trifluoromethyl)Phenyl)-2-MethylpropanoMethylpropanoylmethylamino]-4-(4-Fluoro-2-Methylphenyl)]-2-Pyridinyl-2-Alkyl-Prolinamide As NK1 Receptor Antagonists |
| 03/10/2011 | US20110060013 Thiazoles and pyrazoles useful as kinase inhibitors |
| 03/10/2011 | US20110060012 4-[3-(aryloxy)benzylidene]-3-methyl piperidine 5-membered aryl carboxamide compounds useful as faah inhibitors |
| 03/10/2011 | US20110060010 Salts of 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)piperidine-2,6-dione and derivatives thereof, or polymorphs of salts, process for preparing same and use thereof |
| 03/10/2011 | US20110060009 Hydroxamate-Based Inhibitors of Deacetylases |
| 03/10/2011 | US20110060006 Functionally Selective Alpha2C Adrenoreceptor Agonists |
| 03/10/2011 | US20110059992 New Compounds |
| 03/10/2011 | US20110059989 3,5-diamino-6-chloro-pyrazine-2-carboxylic acid derivatives and their use as epithelial sodium channel blockers for the treatment of airway diseases |
| 03/10/2011 | US20110059983 Use of substituted oxindole derivatives for the treatment and prophylaxis of pain |
| 03/10/2011 | US20110059979 Piperidine/Cyclohexane Carboxamide Derivatives For Use as Vanilloid Receptor Modulators |
| 03/10/2011 | US20110059978 Pyridazinyl amine derivatives, the use thereof in the preparation of picorna virus inhibitors |
| 03/10/2011 | US20110059973 Pyrazole Compounds for Controlling Invertebrate Pests |
| 03/10/2011 | US20110059971 Derivatives of 4-aminopiperidine and their use as a medicament |
| 03/10/2011 | US20110059970 4-phenyl-1,3-thiazoles and 4-phenyl-1,3-oxazoles derivatives as cannabinoid receptor ligands |
| 03/10/2011 | US20110059969 Piperazines as anti-obesity agents |
| 03/10/2011 | US20110059968 Carboxamide compounds and their use as calpain inhibitors |
| 03/10/2011 | US20110059964 Pyrazole derivatives and use thereof as orexin receptor antagonists |
| 03/10/2011 | US20110059962 Transcription factor modulating compounds and methods of use thereof |
| 03/10/2011 | US20110059959 Novel multicyclic compounds and the use thereof |
| 03/10/2011 | US20110059955 Novel 3-aminoalkyl-1,3-dihydro-2h-indol-2-one derivatives, preparation thereof and therapeutic use thereof |
| 03/10/2011 | US20110059954 Cgrp antagonists |
| 03/10/2011 | US20110059952 3-substituted-1,4-diazepan-2-one melanocortin-5 receptor antagonists |
| 03/10/2011 | US20110059950 Aniline derivative having anti-rna viral activity |
| 03/10/2011 | US20110059948 Quinoline, naphthalene and conformationally constrained quinoline or naphthalene derivatives as anti-mycobacterial agents |
| 03/10/2011 | US20110059942 Azetidinyl G-Protein Coupled Receptor Agonists |
| 03/10/2011 | US20110059939 Therapeutic compounds |
| 03/10/2011 | US20110059938 New chemical compounds |
| 03/10/2011 | US20110059937 Il-8 receptor antagonists |
| 03/10/2011 | US20110059935 Beta-LACTAMYL VASOPRESSIN V1a ANTAGONISTS |
| 03/10/2011 | US20110059931 Biphenyl compounds useful as muscarinic receptor antagonists |
| 03/10/2011 | US20110059929 SUBSTITUTED BICYCLIC PIPERIDINYL-AND PIPERAZINYL- SULFONAMIDES USEFUL TO INHIBIT 11beta-HYDROXYSTEROID DEHYDROGENASE TYPE-1 |
| 03/10/2011 | US20110059154 Ccr5 antagonists as prophylactics for preventing hiv infection and methods of inhibiting transmission of same |
| 03/10/2011 | US20110059043 Chemical compounds |
| 03/10/2011 | US20110059019 Novel aryl piperazine derivatives useful as modulators of dopamine and serotonin receptors |
| 03/10/2011 | CA2773038A1 Mglur4 allosteric potentiators, compositions, and methods of treating neurological dysfunction |
| 03/10/2011 | CA2773012A1 Process for the preparation of lenalidomide |
| 03/10/2011 | CA2772790A1 Substituted aminoquinoxalines as tyrosine threonine kinase inhibitors |
| 03/10/2011 | CA2772718A1 Compounds as tyrosine kinase modulators |
| 03/10/2011 | CA2772714A1 Heterocyclic compounds for the inhibition of pask |
| 03/10/2011 | CA2772642A1 Quinazolines as potassium ion channel inhibitors |
| 03/10/2011 | CA2772484A1 Bis-benzimidazole derivatives |
| 03/10/2011 | CA2772265A1 Pyrazinylpyridines useful for the treatment of proliferative diseases |
| 03/10/2011 | CA2772194A1 Benzimidazole derivatives |
| 03/10/2011 | CA2771822A1 Bruton's tyrosine kinase inhibitors |
| 03/10/2011 | CA2771568A1 Heteroaryl compounds as kinase inhibitors |
| 03/10/2011 | CA2771563A1 Bipyridines useful for the treatment of proliferative diseases |
| 03/09/2011 | EP2292615A1 Quinazoline compounds |
| 03/09/2011 | EP2292614A1 Substituted pyrimidines as aurora kinase inhibitors |
| 03/09/2011 | EP2292612A2 Crystalline solvated forms of (R)-2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl]sulfinyl]-1H-benzimidazole |
| 03/09/2011 | EP2292608A1 Intermediates for the preparation of substituted Aminosalicylic acid amides with fungicidal activity |
| 03/09/2011 | EP2292604A2 Condensed-cyclic compound and organic light emitting diode having organic layer including the same |
| 03/09/2011 | EP2292601A1 Phenanthro[2,3-b]pyrroles and Phenanthro[3,2-b]pyrroles for organic light-emitting devices |
| 03/09/2011 | EP2292595A1 Potassium channel modulators |
| 03/09/2011 | EP2292227A2 Pyrazole derivatives modulators of hepatocyte growth factor (scatter factor) activity |
| 03/09/2011 | EP2291366A2 Preparation of imatinib mesylate |
| 03/09/2011 | EP2291365A1 5-substituted isoindoline compounds |
| 03/09/2011 | EP2291359A1 Phenyl or pyridinyl substituted indazoles derivatives |